Andre Schulten, Chief Financial Officer of Procter & Gamble Co, filed a Form 4 on November 9, 2026, disclosing a stock option exercise and same-day share sale executed on November 5, 2026.

Key Highlights

  • Option exercise: Schulten exercised stock options covering 30,677 shares of Common Stock at an exercise price of $78.52 per share on November 5, 2026.
  • Shares sold: 30,677 shares of Common Stock were disposed of on November 5, 2026, at a price of $169 per share.
  • Direct holdings after transactions: Schulten directly owned 65,618.0097 shares of Common Stock following the reported transactions.
  • Indirect holdings: An additional 7,604.419 shares are held indirectly by a Retirement Plan Trustee, according to the filing.
  • Options extinguished: Following the exercise, the number of stock options (right to buy) beneficially owned dropped to 0, with the original expiration date listed as February 28, 2028.

CFO Schulten's Option Exercise and Share Sale at Procter & Gamble

According to the Form 4 filed with the SEC, Andre Schulten, identified in the filing as Chief Financial Officer of Procter & Gamble Co (NYSE:PG), reported two transactions in the company's Common Stock on November 5, 2026. The first was the exercise of stock options with a transaction code of "M," covering 30,677 shares at a conversion price of $78.52. The options carried an original exercisable date of February 26, 2021, and an expiration date of February 28, 2028, and carried a derivative security price of $0 at exercise.

The second transaction, coded "S," reflects the disposal of 30,677 shares at a price of $169 per share. Following both transactions, the filing reports that Schulten directly holds 65,618.0097 shares of Procter & Gamble Common Stock. An indirect position of 7,604.419 shares is also listed, held by a Retirement Plan Trustee on Schulten's behalf. Prior to the sale, the filing shows Schulten's direct holdings stood at 96,295.0097 shares following the option exercise but before the disposal.

The filing was signed by Jennifer Dollard-Smith as attorney-in-fact for Andre Schulten and submitted on November 9, 2026. No amendment date is indicated, suggesting this is an original filing. The filing does not indicate whether the transaction was made pursuant to a Rule 10b5-1 trading plan.

What Was Disclosed

The filing disclosed an option exercise of 30,677 Procter & Gamble Common Stock shares at $78.52, followed by a same-day sale of the same number of shares at $169, leaving Schulten with a direct beneficial ownership of 65,618.0097 shares.